Abstract:BackgroundThe efficacy of triple therapy (pegylated-interferon/ribavirin with boceprevir (BOC) or telaprevir (TVR) in phase III trials is known but not the effectiveness of HCV treatment in clinical practice.PurposeTo investigate the effectiveness and safety of triple therapy with protease inhibitors TVR or BOC in the treatment of patients with Hepatitis C Virus (HCV) in clinical practice.Material and methodsA retrospective observational study with HCV-infected patients treated with TVR or BOC who had complete… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.